STRUCTURE-ACTIVITY STUDY OF THE C-TERMINAL RESIDUE OF MEN-10207 TACHYKININ ANTAGONIST

被引:9
|
作者
ROVERO, P
QUARTARA, L
ASTOLFI, M
PATACCHINI, R
GIACHETTI, A
MAGGI, CA
机构
[1] A MENARINI PHARMACEUT,DEPT CHEM,I-50131 FLORENCE,ITALY
[2] A MENARINI PHARMACEUT,DEPT PHARMACOL,I-50131 FLORENCE,ITALY
[3] MENARINI SUD,DEPT PHARMACOL,POMEZIA,ITALY
关键词
NEUROKININ-A; NK-2 TACHYKININ RECEPTOR SUBTYPES; TACHYKININ ANTAGONISTS;
D O I
10.1016/0196-9781(92)90164-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The role of the C-terminal residue in the sequence of the NK-2- selective tachykinin antagonist, MEN 10207 (Asp-Tyr-D-Trp-Val-D-Trp-D-Trp-Arg-NH2). has been examined by systematic amino acid substitutions. Biological activity has been measured on two in vitro preparations chosen as paradigms of the recently described NK-2 receptor subtypes, namely the rabbit pulmonary artery and the hamster trachea, in order to define the structural requirements necessary for antagonist subtype selectivity. We conclude that in the presence of a C-terminal hydrophilic residue, affinity is maximal for the NK-2A subtype. while hydrophobic. bulky and aromatic residues increase affinity for the NK-2B subtype.
引用
收藏
页码:207 / 208
页数:2
相关论文
共 50 条
  • [41] STRUCTURE-ACTIVITY STUDIES ON ENDOTHELIN (16-21), THE C-TERMINAL HEXAPEPTIDE OF THE ENDOTHELINS, IN THE GUINEA-PIG BRONCHUS
    ROVERO, P
    PATACCHINI, R
    MAGGI, CA
    BRITISH JOURNAL OF PHARMACOLOGY, 1990, 101 (01) : 232 - 234
  • [42] Peptide-based inhibitors of the hepatitis C virus NS3 protease:: Structure-activity relationship at the C-terminal position
    Rancourt, J
    Cameron, DR
    Gorys, V
    Lamarre, D
    Poirier, M
    Thibeault, D
    Llinàs-Brunet, M
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (10) : 2511 - 2522
  • [43] Synthesis and study of a cyclic angiotensin II antagonist analogue reveals the role of π*-π* interactions in the C-terminal aromatic residue for agonist activity and its structure resemblance with AT1 non-peptide antagonists
    Polevaya, L
    Mavromoustakos, T
    Zoumboulakis, P
    Grdadolnik, SG
    Roumelioti, P
    Giatas, N
    Mutule, I
    Keivish, T
    Vlahakos, DV
    Iliodromitis, EK
    Kremastinos, DT
    Matsoukas, J
    BIOORGANIC & MEDICINAL CHEMISTRY, 2001, 9 (06) : 1639 - 1647
  • [44] STRUCTURE ACTIVITY STUDIES ON THE C-TERMINAL AMIDE OF SUBSTANCE-P
    ESCHER, E
    COUTURE, R
    POULOS, C
    PINAS, N
    MIZRAHI, J
    THEODOROPOULOS, D
    REGOLI, D
    JOURNAL OF MEDICINAL CHEMISTRY, 1982, 25 (11) : 1317 - 1321
  • [45] STRUCTURE-ACTIVITY-RELATIONSHIPS OF C-TERMINAL ENDOTHELIN HEXAPEPTIDE ANTAGONISTS
    DOHERTY, AM
    CODY, WL
    DEPUE, PL
    HE, JX
    WAITE, LA
    LEONARD, DM
    LEITZ, NL
    DUDLEY, DT
    RAPUNDALO, ST
    HINGORANI, GP
    HALEEN, SJ
    LADOUCEUR, DM
    HILL, KE
    FLYNN, MA
    REYNOLDS, EE
    JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (18) : 2585 - 2594
  • [46] STRUCTURE-ACTIVITY-RELATIONSHIPS OF ENDOTHELIN - IMPORTANCE OF THE C-TERMINAL MOIETY
    KIMURA, S
    KASUYA, Y
    SAWAMURA, T
    SHINMI, O
    SUGITA, Y
    YANAGISAWA, M
    GOTO, K
    MASAKI, T
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 156 (03) : 1182 - 1186
  • [47] A STRUCTURE-FUNCTION STUDY OF C-TERMINAL EXTENSIONS OF BOMBESIN
    MERVIC, M
    MOODY, TW
    KOMORIYA, A
    PEPTIDES, 1991, 12 (05) : 1149 - 1151
  • [48] STRUCTURE-ACTIVITY RELATIONSHIP STUDY OF R396, AN NK(2) TACHYKININ ANTAGONIST SELECTIVE FOR THE NK(2B) RECEPTOR SUBTYPE
    ROVERO, P
    ASTOLFI, M
    MANZINI, S
    JUKIC, D
    ROUISSI, N
    MAGGI, CA
    REGOLI, D
    NEUROPEPTIDES, 1992, 23 (03) : 143 - 145
  • [49] STUDY ON THE SECONDARY STRUCTURE OF CALDESMON AND ITS C-TERMINAL FRAGMENTS
    CZURYLO, EA
    VENYAMINOV, SY
    DABROWSKA, R
    JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY, 1993, 14 (02) : 239 - 240
  • [50] Structure-activity study of L-cysteine-based N-type calcium channel blockers: Optimization of N- and C-terminal substituents
    Seko, T
    Kato, M
    Kohno, H
    Ono, S
    Hashimura, K
    Takimizu, H
    Nakai, K
    Maegawa, H
    Katsube, N
    Toda, M
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (06) : 915 - 918